FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

S Tredici

Research Profile

Procedures

Chemicals & Drugs

Anatomy

Hematopoietic Stem Cells

Disorders

Concepts & Ideas

Feasibility Studies

Co-author Network

Publications

TOP 3
Manlio Mencoboni; M Bergaglio; M Serra; Gian Paolo Ivaldi; S Tredici; O Racchi; L Rebella; V Galbusera; Marco Grosso; B Faravelli
Maintenance therapy with gefitinib after first-line chemotherapy in patients affected by advanced non-small cell lung cancer.
M Mencobonii; S Tredici; L Rebella; M Bergaglio; V Galbusera; A Manzara; F Claudiani; B Malcangi; Marco Varaldo
Effect of chemotherapy on somatostatin receptor detection with octreotide scintigraphy in hormone-refractory prostate cancer patients.
Manlio Mencoboni; S Tredici; Marco Varaldo; G Queirolo; F Durand; L Rebella; V Galbusera; Ivo Pannacciulli; Riccardo Ghio
Chemoimmunotherapy with low dose vinorelbine and interleukin-2 in treatment of patients with metastatic renal cell carcinoma.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of S Tredici (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2007: Manlio Mencoboni; M Bergaglio; M Serra; Gian Paolo Ivaldi; S Tredici; O Racchi; L Rebella; V Galbusera; Marco Grosso; B Faravelli
Maintenance therapy with gefitinib after first-line chemotherapy in patients affected by advanced non-small cell lung cancer.
Anticancer research 2007;27(6C):4425-9.
2006: M Mencobonii; S Tredici; L Rebella; M Bergaglio; V Galbusera; A Manzara; F Claudiani; B Malcangi; Marco Varaldo
Effect of chemotherapy on somatostatin receptor detection with octreotide scintigraphy in hormone-refractory prostate cancer patients.
Anticancer research 2006;26(3B):2233-5.
2006: Manlio Mencoboni; S Tredici; Marco Varaldo; G Queirolo; F Durand; L Rebella; V Galbusera; Ivo Pannacciulli; Riccardo Ghio
Chemoimmunotherapy with low dose vinorelbine and interleukin-2 in treatment of patients with metastatic renal cell carcinoma.
Neoplasma 2006;53(4):333-6.
2005: Manlio Mencoboni; L Rebella; S Tredici; Riccardo Ghio; D Scarpati; M Bavazzano; B Jankowska; M Delle Piane
Concurrent chemo-radiotherapy with taxotere and cisplatin in head and neck cancer: a feasibility study.
Anticancer research 2005;25(6C):4451-4.
2005: Manlio Mencoboni; L Rebella; S Tredici; M Bergaglio; M Delle Piane; Angelo Salami; M Bavazzano; Riccardo Ghio; A Grimaldi; D Scarpati
Concurrent radio-chemotherapy with docetaxel and cisplatinum in inoperable or relapsed head and neck cancer.
I supplementi di Tumori : official journal of Società italiana di cancerologia ... [et al.] 2005;4(3):S215.
1999: Roberto Lerza; G Castello; M Truini; P Ballarino; S Tredici; D Cavallini; Ivo Pannacciulli
Splenectomy induced complete remission in a patient with multicentric Castleman's disease and autoimmune hemolytic anemia.
Annals of hematology 1999;78(4):193-6.
1999: Ivo Pannacciulli; P Ballarino; G Castello; Eleonora Arboscello; Marco Botta; S Tredici; Roberto Lerza
In vitro toxicity of taxol based anticancer drug combinations on human hemopoietic progenitors.
Anticancer research 1999;19(1A):409-12.
1998: Roberto Lerza; G Castello; P Ballarino; Giuseppe Sandro Mela; S Tredici; Eleonora Arboscello; Manlio Mencoboni; Ivo Pannacciulli
In vitro toxicity of A 3'-azido-3'-deoxythymidine and hydroxyurea combination on normal myeloid progenitors.
Anticancer research 1998;18(4A):2755-8.